Systematic Review of the Risk of Adverse Outcomes Associated with Vascular Endothelial Growth Factor Inhibitors for the Treatment of Cancer

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

(2013) T. T. Batchelor et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bevacizumab and Wound-Healing Complications

(2012) Ketan Sharma et al.   ANNALS OF PLASTIC SURGERY

Selected adverse events in cancer patients treated with vascular endothelial growth factor inhibitors

(2012) Brian Dreyfus et al.   Cancer Epidemiology

An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases

(2012) Alan Sandler et al.   LUNG CANCER

Side effects of anti-angiogenic drugs

(2012) Francesca Elice et al.   THROMBOSIS RESEARCH

Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials

(2011) Chris Coppin et al.   BJU INTERNATIONAL

Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion

(2011) A. G. Sorensen et al.   CANCER RESEARCH

An Algorithm for the Management of Hypertension in the Setting of Vascular Endothelial Growth Factor Signaling Inhibition

(2011) M. Sitki Copur et al.   Clinical Colorectal Cancer

Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials

(2011) Xiao Feng Hang et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Treatment-Related Mortality With Bevacizumab in Cancer Patients

(2011) Vishal Ranpura et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies

(2011) Herbert I. Hurwitz et al.   JOURNAL OF CLINICAL ONCOLOGY

VEGF pathway-targeted therapy for advanced renal cell carcinoma: A meta-analysis of randomized controlled trials

(2011) Fei Liu et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

Crescentic glomerulonephritis associated with vascular endothelial growth factor (VEGF) inhibitor and bisphosphonate administration

(2011) K. Stylianou et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Bevacizumab Treatment for Advanced Breast Cancer

(2011) R. H. Alvarez et al.   ONCOLOGIST

Noncardiac Vascular Toxicities of Vascular Endothelial Growth Factor Inhibitors in Advanced Cancer: A Review

(2011) D. Keefe et al.   ONCOLOGIST

Effectiveness and Safety of Bevacizumab for Unresectable Non-Small-Cell Lung Cancer

(2010) Kun Yang et al.   CLINICAL DRUG INVESTIGATION

Stopping Randomized Trials Early for Benefit and Estimation of Treatment EffectsSystematic Review and Meta-regression Analysis

(2010) Dirk Bassler   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis

(2010) Sanjaykumar Hapani et al.   ONCOLOGY

Renal Effects of Anti-angiogenesis Therapy: Update for the Internist

(2009) Faina Gurevich et al.   AMERICAN JOURNAL OF MEDICINE

VEGF kinase inhibitors: how do they cause hypertension?

(2009) Pankaj Bhargava   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Management of hypertension in angiogenesis inhibitor-treated patients

(2009) H. Izzedine et al.   ANNALS OF ONCOLOGY

A Review on Bevacizumab and Surgical Wound Healing

(2009) Chad R. Gordon et al.   ANNALS OF PLASTIC SURGERY

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

(2009) Youjin Je et al.   LANCET ONCOLOGY

Renal toxicity of targeted therapies

(2009) Ronan J. Kelly et al.   Targeted Oncology

Cardiovascular toxicities: clues to optimal administration of vascular endothelial growth factor signaling pathway inhibitors

(2009) Kelly L. Snider et al.   Targeted Oncology

Home Blood-Pressure Monitoring in Patients Receiving Sunitinib

(2008) Michel Azizi et al.   NEW ENGLAND JOURNAL OF MEDICINE